VanEck Associates’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.72M | Buy |
20,456
+5,525
| +37% | +$1.98M | 0.01% | 715 |
|
|
2025
Q4 | $5.25M | Buy |
14,931
+1,488
| +11% | +$542K | ﹤0.01% | 763 |
|
|
2025
Q3 | $4.97M | Buy |
13,443
+469
| +4% | +$181K | ﹤0.01% | 773 |
|
|
2025
Q2 | $5.13M | Buy |
12,974
+339
| +3% | +$127K | 0.01% | 719 |
|
|
2025
Q1 | $4.7M | Sell |
12,635
-400
| -3% | -$152K | 0.01% | 734 |
|
|
2024
Q4 | $4.69M | Buy |
13,035
+173
| +1% | +$64.1K | 0.01% | 718 |
|
|
2024
Q3 | $4.67M | Sell |
12,862
-259
| -2% | -$89.4K | 0.01% | 669 |
|
|
2024
Q2 | $4.46M | Buy |
13,121
+507
| +4% | +$172K | 0.01% | 613 |
|
|
2024
Q1 | $4.51M | Sell |
12,614
-727
| -5% | -$245K | 0.01% | 620 |
|
|
2023
Q4 | $4M | Sell |
13,341
-174
| -1% | -$48.8K | 0.01% | 608 |
|
|
2023
Q3 | $3.69M | Buy |
13,515
+2,683
| +25% | +$769K | 0.01% | 582 |
|
|
2023
Q2 | $3.31M | Sell |
10,832
-63
| -0.6% | -$18.2K | 0.01% | 611 |
|
|
2023
Q1 | $3.11M | Sell |
10,895
-220
| -2% | -$58.4K | 0.01% | 597 |
|
|
2022
Q4 | $2.72M | Buy |
11,115
+2,404
| +28% | +$546K | 0.01% | 604 |
|
|
2022
Q3 | $1.76M | Buy |
8,711
+120
| +1% | +$25.2K | 0.01% | 677 |
|
|
2022
Q2 | $1.71M | Buy |
8,591
+236
| +3% | +$55.4K | ﹤0.01% | 686 |
|
|
2022
Q1 | $2.23M | Sell |
8,355
-5,059
| -38% | -$1.31M | ﹤0.01% | 676 |
|
|
2021
Q4 | $3.59M | Buy |
13,414
+205
| +2% | +$53.8K | 0.01% | 583 |
|
|
2021
Q3 | $3.48M | Buy |
13,209
+4,243
| +47% | +$1.13M | 0.01% | 539 |
|
|
2021
Q2 | $2.33M | Sell |
8,966
-184
| -2% | -$47.1K | 0.01% | 624 |
|
|
2021
Q1 | $2.23M | Buy |
9,150
+469
| +5% | +$112K | 0.01% | 587 |
|
|
2020
Q4 | $2.13M | Buy |
8,681
+42
| +0.5% | +$9.51K | 0.01% | 535 |
|
|
2020
Q3 | $1.8M | Sell |
8,639
-11,044
| -56% | -$2.15M | 0.01% | 517 |
|
|
2020
Q2 | $3.55M | Sell |
19,683
-6,172
| -24% | -$1.14M | 0.01% | 383 |
|
|
2020
Q1 | $4.3M | Sell |
25,855
-2,932
| -10% | -$573K | 0.02% | 337 |
|
|
2019
Q4 | $6.04M | Buy |
28,787
+1,179
| +4% | +$245K | 0.02% | 341 |
|
|
2019
Q3 | $5.97M | Buy |
27,608
+871
| +3% | +$187K | 0.03% | 310 |
|
|
2019
Q2 | $5.5M | Buy |
26,737
+2,383
| +10% | +$455K | 0.03% | 321 |
|
|
2019
Q1 | $4.81M | Buy |
24,354
+20,245
| +493% | +$3.64M | 0.02% | 317 |
|
|
2018
Q4 | $644K | Buy |
4,109
+117
| +3% | +$19.6K | ﹤0.01% | 609 |
|
|
2018
Q3 | $709K | Sell |
3,992
-53
| -1% | -$9.05K | ﹤0.01% | 630 |
|
|
2018
Q2 | $683K | Buy |
+4,045
| New | +$680K | ﹤0.01% | 628 |
|
Other funds holding SYK
VCM
GT
VPM
VanEck Associates's SYK Position: Q1 2026 in Review
VanEck Associates increased its Stryker (SYK) stake by 37% in Q1 2026, buying an estimated $1.98M and bringing the position to 20,456 shares worth $6.72M. The position accounts for 0.01% of the portfolio, ranked #715.
VanEck Associates first reported a position in SYK in Q2 2018 and has held it in 32 quarters since. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.
- VanEck Associates held 20,456 shares of Stryker worth $6.72M as of Q1 2026.
- VanEck Associates bought 5,525 Stryker shares in Q1 2026, an estimated $1.98M.
- Stryker made up 0.01% of VanEck Associates's portfolio in Q1 2026, its #715 holding.
- VanEck Associates first reported a position in Stryker in Q2 2018 and has held it in 32 quarters since.
- 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.
Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.